FIGURE 5.
The effects of tMCAO and XFZYD on the colocalization of AQP4, α-DG and β-DG. (A) The immunostaining of AQP4, α-DG and β-DG in the infarct and periinfarct areas (Scale bars, 200μm and 500 μm). (B) Quantitative analysis of data A in infarct area and periinfarct area. (C) Representative colocalization images of AQP4, α-DG and β-DG immunostaining in the meningeal (α-DG, left; β-DG, right, Scale bar, 10 μm). (D) Quantification of the colocalization of AQP4, α-DG and β-DG by Manders’ tM1, Manders’ tM2 and Pearson’s R value in different groups. (* p < 0.05, ** p < 0.01, *** p < 0.001 vs. the sham group, # p < 0.05, ### p < 0.001 vs. the tMCAO group; Data represent mean ± SD, n = 6).